Cell Culture Market Growth 2023 to 2033 | By Corning, Merck KgaA, PromoCell, Danaher, Sartorius

The global Cell Culture Market Size is expected to be worth US$ 25.4 billion in 2022 and US$ 29 billion in 2023. Furthermore, with increased R&D activities and rising demand for biopharmaceuticals such as vaccines and stem cells, the global Cell Culture market is expected to grow at an amazing 11.8% CAGR between 2023 and 2033, reaching a valuation of roughly US$ 88.6 billion by 2033.

As per FMI, the key market drivers during the forecast period are:

• Acceleration of R&D operations to help with biopharmaceutical mass production
• Cell Culture-based products are becoming more popular.
• Widespread application in pharmaceutical companies, research institutes, and food development
• Chronic disorders that demand medical progress
• Consumer interest in monoclonal antibodies (mAbs) is growing.

Request a report sample to gain compressive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14318

Cell Culture Application in Pharma & Health is Key to Market Growth

At the moment, innovation is fueling market expansion. As many end-user segments invest heavily in Cell Culture research and development, demand for enhanced variations of Cell Culture items is expanding. Similarly, there is a greater need for novel therapies, such as biosimilars, which improve market prospects.

All of these factors have combined to create a one-of-a-kind use of Cell Culture in the pharmaceutical and healthcare industries. This is primarily due to an increase in cancer, kidney disease, diabetes, and cardiovascular disease. With rising customer demand for more effective treatment options, Cell Culture may present profitable prospects for the pharmaceutical and healthcare businesses.

Key Players Need to Find a Way Out of Market Bottlenecks to Aid Growth

Extensive cell biology research is required for product development. However, this necessitates a considerable outlay of funds. To produce high-end items that meet tight regulatory criteria, manufacturers must spend in high-quality equipment and other inputs. Smaller firms are so limited in their access to Cell Culture resources. The same is true for research institutions with limited resources. Even further down the industrial chain, manufacturers must invest time and technical capabilities in cell harvesting. If big enterprises can overcome these technical roadblocks, the industry could expand even further in the coming years.

Last few days to get reports at discounted prices, offer expires soon!

Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-14318

Key Takeaways from the Report:

• The market grew at a 13.5% CAGR between 2017 and 2022, reaching a valuation of US$ 25.4 billion by 2022.
• During the projected period, the US market is expected to increase at an 11.6% CAGR, reaching a valuation of US$ 31.4 billion by 2033.
• The market in the United Kingdom is expected to increase at a CAGR of 10.9% between 2023 and 2033, reaching a value of US$ 3.7 billion by 2033.
• The consumables segment is predicted to grow at a 11.4% CAGR throughout the projection period.
• The biopharmaceutical production segment is predicted to develop at an 11.1% CAGR over the forecast period.

Key Market Developments:

• In January 2022, Cytiva (Danaher Corporation) announced its collaboration with Nucleus Biologics. This can be an important step towards developing custom culture media for cell as well as gene therapies.
• In February 2022, KromaTiD enhanced its services by venturing into cell and blood culture isolation, and processing, coupled with quality control services

Key Players:

• Danaher Corporation
• Thermo Fisher Scientific
• Becton
• Dickinson and Company
• Corning Incorporated
• Merck KgaA
• PromoCell GmbH
• Sartorius AG

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-14318

Key Segments

By Product:

• Consumables
  • Sera
  • Media
  • Reagents
  • Vessels
  • Accessories
• Equipment
  • Supporting Equipment
  • Bioreactors
  • Storage Equipment

By Application:

• Biopharmaceutical Production
  • Monoclonal antibodies
  • Vaccines production
  • Other therapeutic proteins
• Diagnostics
  • Drug Screening & Development
    • Tissue Engineering & Regenerative Medicine
  • Cell and gene therapy
• Others

By End User:

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Others

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs